Skip to main content

Table 3 Clinical characteristics of patients

From: A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

Number 16
Mean Age 51.8 (35–75 years)
Histology  
Squamous 16 (100%)
FIGO Stage*  
IIB 8 (50%)
IIIB 8 (50%)
Performance Status**  
0 10 (62%)
1 6 (38%)
  1. *International Federation of Gynecology and Obstetrics,
  2. ** World Health Organization Criteria